Skip to main content

Propel Bio Management, LLC

SEC CIK
0001969764
Latest filing
Aug 13, 2026

CHRS holding history

Coherus Oncology, Inc. in every 13F filed by Propel Bio Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CHRS overviewAll 13F holders of CHRSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q1 2026
Holdings of CHRS by Propel Bio Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−1,420,550−100.0%Sold outHolders
Q1 20261,420,550$2.41M1.5%+1,420,550NewHolders